| Title |
Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
|
|---|---|
| Published in |
PLOS ONE, January 2012
|
| DOI | 10.1371/journal.pone.0029794 |
| Pubmed ID | |
| Authors |
Daniel A. Monti, Edith Mitchell, Anthony J. Bazzan, Susan Littman, George Zabrecky, Charles J. Yeo, Madhaven V. Pillai, Andrew B. Newberg, Sandeep Deshmukh, Mark Levine |
| Abstract |
Preclinical data support further investigation of ascorbic acid in pancreatic cancer. There are currently insufficient safety data in human subjects, particularly when ascorbic acid is combined with chemotherapy. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 43% |
| Hungary | 1 | 14% |
| Canada | 1 | 14% |
| United Kingdom | 1 | 14% |
| Unknown | 1 | 14% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 2% |
| Colombia | 1 | <1% |
| Denmark | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 171 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 27 | 15% |
| Researcher | 22 | 12% |
| Student > Doctoral Student | 21 | 12% |
| Student > Master | 19 | 11% |
| Student > Ph. D. Student | 17 | 10% |
| Other | 38 | 21% |
| Unknown | 34 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 36% |
| Biochemistry, Genetics and Molecular Biology | 25 | 14% |
| Agricultural and Biological Sciences | 15 | 8% |
| Nursing and Health Professions | 9 | 5% |
| Psychology | 6 | 3% |
| Other | 16 | 9% |
| Unknown | 43 | 24% |